Compare PBF & LIVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PBF | LIVN |
|---|---|---|
| Founded | 2008 | 1987 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Integrated oil Companies | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 3.5B |
| IPO Year | 2012 | 1993 |
| Metric | PBF | LIVN |
|---|---|---|
| Price | $30.49 | $62.71 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 12 | 7 |
| Target Price | $30.83 | ★ $62.43 |
| AVG Volume (30 Days) | ★ 2.5M | 602.4K |
| Earning Date | 10-30-2025 | 11-05-2025 |
| Dividend Yield | ★ 3.62% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $29,544,100,000.00 | $1,348,962,000.00 |
| Revenue This Year | N/A | $12.25 |
| Revenue Next Year | $3.20 | $6.75 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 8.63 |
| 52 Week Low | $13.62 | $32.48 |
| 52 Week High | $41.48 | $65.57 |
| Indicator | PBF | LIVN |
|---|---|---|
| Relative Strength Index (RSI) | 33.94 | 61.66 |
| Support Level | $30.04 | $61.81 |
| Resistance Level | $34.32 | $65.57 |
| Average True Range (ATR) | 1.53 | 1.88 |
| MACD | -0.61 | -0.02 |
| Stochastic Oscillator | 7.88 | 62.28 |
PBF Energy Inc is an independent petroleum refiner and supplier of unbranded transportation fuels, heating oil, petrochemical feedstocks, lubricants, and other petroleum products in the United States. The company owns refineries in Delaware, Ohio, New Jersey, California, and Louisiana. The Company operates in two reportable business segments: Refining and Logistics. The Company's oil refineries are all engaged in the refining of crude oil and other feedstocks into petroleum products and are aggregated into the Refining segment. PBFX operates logistics assets such as crude oil and refined products terminals, pipelines and storage facilities. The Logistics segment consists solely of PBFX's operations.
UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.